Refine
Document Type
- Article (5)
- Preprint (2)
- Diploma Thesis (1)
- Doctoral Thesis (1)
Has Fulltext
- yes (9)
Is part of the Bibliography
- no (9)
Keywords
- ATM (1)
- Atom (1)
- Brain tumor (1)
- Glioma (1)
- Heavy-ion detectors (1)
- Ionisation (1)
- Large detector systems for particle and astroparticle physics (1)
- Laser (1)
- Molecular matched therapy (1)
- Molecular profiling (1)
Institute
- Physik (5)
- Medizin (4)
- Frankfurt Institute for Advanced Studies (FIAS) (3)
- Informatik (3)
A Large Ion Collider Experiment (ALICE) has been conceived and constructed as a heavy-ion experiment at the LHC. During LHC Runs 1 and 2, it has produced a wide range of physics results using all collision systems available at the LHC. In order to best exploit new physics opportunities opening up with the upgraded LHC and new detector technologies, the experiment has undergone a major upgrade during the LHC Long Shutdown 2 (2019-2022). This comprises the move to continuous readout, the complete overhaul of core detectors, as well as a new online event processing farm with a redesigned online-offline software framework. These improvements will allow to record Pb-Pb collisions at rates up to 50 kHz, while ensuring sensitivity for signals without a triggerable signature.
A Large Ion Collider Experiment (ALICE) has been conceived and constructed as a heavy-ion experiment at the LHC. During LHC Runs 1 and 2, it has produced a wide range of physics results using all collision systems available at the LHC. In order to best exploit new physics opportunities opening up with the upgraded LHC and new detector technologies, the experiment has undergone a major upgrade during the LHC Long Shutdown 2 (2019–2022). This comprises the move to continuous readout, the complete overhaul of core detectors, as well as a new online event processing farm with a redesigned online-offline software framework. These improvements will allow to record Pb-Pb collisions at rates up to 50 kHz, while ensuring sensitivity for signals without a triggerable signature.
A Large Ion Collider Experiment (ALICE) has been conceived and constructed as a heavy-ion experiment at the LHC. During LHC Runs 1 and 2, it has produced a wide range of physics results using all collision systems available at the LHC. In order to best exploit new physics opportunities opening up with the upgraded LHC and new detector technologies, the experiment has undergone a major upgrade during the LHC Long Shutdown 2 (2019-2022). This comprises the move to continuous readout, the complete overhaul of core detectors, as well as a new online event processing farm with a redesigned online-offline software framework. These improvements will allow to record Pb-Pb collisions at rates up to 50 kHz, while ensuring sensitivity for signals without a triggerable signature.
Ziel der durchgeführten Experimente dieser Arbeit war es, den Versuch zu unternehmen, Cooper-Paare als Träger des supraleitenden Stroms direkt mit Hilfe des Photoelektrischen Effektes nachzuweisen. Die Methode der koinzidenten Photoelektronenspektroskopie zielt dabei auf den Nachweis von zwei kohärent emittierten Elektronen durch die Wechselwirkung mit einem Photon ab. Da elektrostatische Analysatoren typischerweise nur einen sehr kleinen Raumwinkel erfassen, was mit sehr geringen Koinzidenzraten einhergeht, ist im Zusammenhang mit dieser Arbeit ein Flugzeitprojektionssystem entwickelt worden, welches nahezu den gesamten Raumwinkel auf einem ortsauflösenden Detektor abbildet. Die zur Messung erforderliche gepulste Lichtquelle in Form von spezieller Synchrotronstrahlung ist so schwach eingestellt worden, daß nur vereinzelt Photonen auf die Probe gelangen konnten. Spektroskopiert wurde neben Testmessungen an Silberschichten sowohl ein Blei-Einkristall als Vertreter der klassischen BCS-Supraleiter als auch einkristallines Bi2Sr2CaCu2O8 aus der Gattung der Hochtemperatursupraleiter. Mit Anregungsenergien bis 40 eV konnte gezeigt werden, daß hinreichend glatte und saubere Oberflächen in der supraleitenden Phase innerhalb des Auflösevermögens von ungefähr 0.5 eV keine erkennbaren, signifikanten Unterschiede im Vergleich zur normalleitenden Phase aufweisen. Neben diesen Untersuchungen ist weiterhin ausführlich die einfache Photoemission an den verschiedenen Proben und insbesondere im Falle des Bleikristalls behandelt, da hier keine vergleichbaren Resultate bekannt sind. Dabei wird der gesamte Impulsraum besprochen und die Fermi-Fläche als dreidimensionales Modell erstellt, mit dessen Hilfe die Meßergebnisse diskutiert werden. In den theoretischen Beschreibungen sind verschiedene Modelle zur Cooper-Paar-Emission vorgestellt, wobei beispielsweise dem Impulsaustausch mit dem Kristall eine besondere Rolle beigemessen wird, da dieser bei direkten Anregungen nur über diskrete Gittervektoren erfolgen kann.
Altered mucosal immune response after acute lung injury in a murine model of Ataxia Telangiectasia
(2014)
Background: Ataxia telangiectasia (A-T) is a rare but devastating and progressive disorder characterized by cerebellar dysfunction, lymphoreticular malignancies and recurrent sinopulmonary infections. In A-T, disease of the respiratory system causes significant morbidity and is a frequent cause of death.
Methods: We used a self-limited murine model of hydrochloric acid-induced acute lung injury (ALI) to determine the inflammatory answer due to mucosal injury in Atm (A-T mutated)- deficient mice (Atm−/−).
Results: ATM deficiency increased peak lung inflammation as demonstrated by bronchoalveolar lavage fluid (BALF) neutrophils and lymphocytes and increased levels of BALF pro-inflammatory cytokines (e.g. IL-6, TNF). Furthermore, bronchial epithelial damage after ALI was increased in Atm−/− mice. ATM deficiency increased airway resistance and tissue compliance before ALI was performed.
Conclusions: Together, these findings indicate that ATM plays a key role in inflammatory response after airway mucosal injury.
Background: Both standard and low-dose allergen provocations are an established tool in asthma research to improve our understanding of the pathophysiological mechanism of allergic asthma. However, clinical symptoms are less likely to be induced. Therefore, we designed a protocol for repetitive high-dose bronchial allergen challenges to generate clinical symptoms and airway inflammation.
Methods: A total of 27 patients aged 18 to 40 years with positive skin-prick tests and mild asthma underwent repetitive high-dose allergen challenges with household dust mites for four consecutive days. Pulmonary function and exhaled NO were measured at every visit. Induced sputum was analysed before and after the allergen challenges for cell counts, ECP, IL-5, INF-γ, IL-8, and the transcription factor Foxp3.
Results: We found a significant decrease in pulmonary function, an increased use of salbutamol and the development of a late asthmatic response and bronchial hyperresponsiveness, as well as a significant induction of eNO, eosinophils, and Th-2 cytokines. Repeated provocation was feasible in the majority of patients. Two subjects had severe adverse events requiring prednisolone to cope with nocturnal asthma symptoms.
Conclusions: Repeated high-dose bronchial allergen challenges resulted in severe asthma symptoms and marked Th-2-mediated allergic airway inflammation. The high-dose challenge model is suitable only in an attenuated form in diseased volunteers for proof-of-concept studies and in clinical settings to reduce the risk of severe asthma exacerbations.
Trial registration: ClinicalTrials.govNCT00677209
Background & aim: Whether inosine triphosphatase (ITPA) gene polymorphisms predict anemia during interferon-free therapy in chronic hepatitis C virus (HCV)-infected patients is unknown. We examined the relationship between two ITPA polymorphisms, anemia, and sustained virological response 12 weeks post-treatment (SVR12) in patients receiving the NS3/4A protease inhibitor faldaprevir, the non-nucleoside polymerase inhibitor deleobuvir, and ribavirin.
Methods: HCV genotype 1-infected, treatment-naïve patients (N = 362) were randomized and treated in one of five treatment arms with faldaprevir and deleobuvir with or without ribavirin. Two ITPA polymorphisms (rs1127354 and rs6051702) were genotyped and defined as ITPA-deficient (rs1127354 AA or AC; rs6051702 CC or CA) or ITPA-non-deficient (rs1127354 CC; rs6051702 AA) according to their association with ITPA deficiency. Baseline and on-treatment variables associated with anemia and SVR12 were identified using logistic regression.
Results: In the pooled ribavirin-containing arms, 10.1% (32/316) of patients experienced on-treatment hemoglobin <10 g/dL, and 32.6% (103/316) experienced on-treatment hemoglobin <10 g/dL or a change from baseline ≥3.5 g/dL. Of the latter group, 99% (102/103) had the ITPA-non-deficient rs1127354 genotype. Other variables associated with on-treatment hemoglobin <10 g/dL or a decrease ≥3.5 g/dL were age, baseline hemoglobin, rs6051702 genotype, and plasma ribavirin concentration. In a multivariate analysis, high plasma ribavirin concentration, low baseline hemoglobin, HCV genotype 1b, and IL28B genotype CC were associated with higher SVR12.
Conclusions: The ITPA rs1127354 CC and rs6051702 AA genotypes may predict ribavirin-induced anemia during treatment with interferon-free, ribavirin-containing regimens. With this interferon-free regimen, SVR was associated with ribavirin levels, but not with anemia or ITPA genotypes.
Purpose: Molecular diagnostics including next generation gene sequencing are increasingly used to determine options for individualized therapies in brain tumor patients. We aimed to evaluate the decision-making process of molecular targeted therapies and analyze data on tolerability as well as signals for efficacy.
Methods: Via retrospective analysis, we identified primary brain tumor patients who were treated off-label with a targeted therapy at the University Hospital Frankfurt, Goethe University. We analyzed which types of molecular alterations were utilized to guide molecular off-label therapies and the diagnostic procedures for their assessment during the period from 2008 to 2021. Data on tolerability and outcomes were collected.
Results: 413 off-label therapies were identified with an increasing annual number for the interval after 2016. 37 interventions (9%) were targeted therapies based on molecular markers. Glioma and meningioma were the most frequent entities treated with molecular matched targeted therapies. Rare entities comprised e.g. medulloblastoma and papillary craniopharyngeoma. Molecular targeted approaches included checkpoint inhibitors, inhibitors of mTOR, FGFR, ALK, MET, ROS1, PIK3CA, CDK4/6, BRAF/MEK and PARP. Responses in the first follow-up MRI were partial response (13.5%), stable disease (29.7%) and progressive disease (46.0%). There were no new safety signals. Adverse events with fatal outcome (CTCAE grade 5) were not observed. Only, two patients discontinued treatment due to side effects. Median progression-free and overall survival were 9.1/18 months in patients with at least stable disease, and 1.8/3.6 months in those with progressive disease at the first follow-up MRI.
Conclusion: A broad range of actionable alterations was targeted with available molecular therapeutics.
However, efficacy was largely observed in entities with paradigmatic oncogenic drivers, in particular with BRAF mutations. Further research on biomarker-informed molecular matched therapies is urgently necessary.
Durch Messen der vollständigen Impulsvektoren beider Coulomb-explodierender, einfachgeladener Fragmente eines doppelionisierten, diatomaren, homonuklearen Moleküls (H2, N2, O2) können verschiedene Ionisationsprozesse identifiziert werden. Bei der sogenannten COLd Target Recoil Ion Momentum Spectroskopy (COLTRIMS) wird ein überschall Gasjet mit ultrakurzen, hochintensiven Laserpulsen penetriert. Aus den gemessenen Fragmentimpulsen kann die freigesetzte kinetische Energie, sowie die ursprüngliche Lage der Molekülachse im Laborsystem berechnet werden, woraus winkelabhängige Explosionswahrscheinlichkeiten abgeleitet werden können, die unter bestimmten Bedingungen die orbitale Symmetrie der Moleküle wiederspiegeln. Unter Benutzung verschiedener Pulslängen des Lasers (35 fs und 8 fs) und Variation der Polarisation (linear, zirkular) koennen Ionisationsmechanismen wie rescattering oder sequentielle Ionisation identifiziert werden.